The OhioHealth Structural Heart Disease Program elevates the care of patients with heart valve disease or other structural heart disorders by providing multidisciplinary collaboration among expert physicians and access to groundbreaking treatments.
The OhioHealth Structural Heart Disease Clinic provides highly specialized evaluation and treatment options all in one location. Located at the OhioHealth Advanced Heart & Vascular Center, the clinic brings together physicians, nurses, researchers and other experts to determine the best course of treatment and offer access to clinical trials testing leading-edge therapies.
An Alternative to Major Surgery
Patients with severe aortic stenosis (narrowing of the aortic valve) who are ineligible for open-heart aortic valve replacement now have alternative treatment options available at OhioHealth.
For patients deemed inoperable for open-heart surgery, a new, FDA-approved procedure, transcatheter aortic valve replacement (TAVR), is now available as an immediate treatment option at Riverside Methodist. The Edwards SAPIEN Transcatheter Heart Valve is used to replace the diseased native heart valve in a catheter-based procedure.
Transcatheter aortic valve replacement (TAVR) procedures take place in a "hybrid room," which is part operating room and part catheterization lab. Patients are managed by a team consisting of a cardiovascular surgeon, an interventional cardiologist, an anesthesiologist, an echocardiographer, a perfusionist and a staff of nurses and radiology technicians.
Read why 88-year-old Eileen felt like doing somersaults
after her TAVR procedure.
Access to Leading-Edge Research
OhioHealth Riverside Methodist Hospital is among a select group of leading U.S. hospitals participating in a nationwide trial that gives hope to people with a life-threatening heart condition. The Medtronic CoreValve U.S. Clinical Trial is evaluating a minimally invasive alternative to open-heart surgery for patients with severe aortic stenosis, a narrowing of the aortic valve that impairs function and diminishes blood flow. Going in through the groin, the shoulder or directly between the ribs, the doctors can insert a bioprosthetic valve through a catheter without removing the native valve.
Watch Riverside Methodist featured in the news and see how the Medtronic CoreValve U.S. Clinical Trial procedure works.
OhioHealth was the first hospital system in Ohio to offer two non-surgical options for treating aortic stenosis.
Innovative Care for Patients with Structural Heart Disease
Catheter-based inventions, like those offered at OhioHealth, are the future of valve replacement and offer many benefits to patients. In particular, the non-invasive approach allows patients to avoid a large chest incision, which reduces the risk of complications and shortens recovery times.
Conditions and Treatments Associated with Structural Heart Disease
Atrial septal defects
Patent foramen ovalves
Ventricular septal defects
Left Atrial Appendage closure
PVRT (Percutaneous Ventricular Restoration Therapy)
TAVR (Transcatheter Heart Valve Replacement)
OhioHealth Care Locations for This Program